Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. H.J. (Henkjan) Verkade

Publications

EASL Clinical Practice Guidelines on genetic cholestatic liver diseases

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice

Obtaining first-line induction in autoimmune hepatitis: aren't we underestimating prednisolone?

Old habits die hard: The age at Kasai portoenterostomy in European infants with biliary atresia

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper

Transmission and dynamics of mother-infant gut viruses during pregnancy and early life

Read more

Press/media

Wat is een vette lever en hoe merk je dat je dat hebt?

Toename acute hepatitis bij jonge kinderen mogelijk door overdraagbare oorzaak

Al drie levertransplantaties na mysterieuze kinderhepatitis: dit weten we inmiddels

RIVM en WHO waarschuwen voor leverziekte onder kinderen

Bijzonder goede prognose voor kinderen na levertransplantatie

Prognose voor kinderen die levertransplantatie ondergaan erg goed

Onderzoek UMCG: Getransplanteerde lever bij kind blijft vaak decennialang werken

Levertransplantaties voor kinderen opvallend succesvol

Interview national radio (NPO1): "Met het oog op morgen"

Read more